Habeck Michael
Количество цитирований статей в журналах по данным
Web of Science: 528,
Scopus: 766
IstinaResearcherID (IRID): 258217829
Деятельность
-
Статьи в журналах
-
-
2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
-
Schmid Peter,
Cortes Javier,
Dent Rebecca,
Pusztai Lajos,
McArthur Heather,
Kümmel Sherko,
Bergh Jonas,
Denkert Carsten,
Park Yeon Hee,
Hui Rina,
Harbeck Nadia,
Takahashi Masato,
Untch Michael,
Fasching Peter A.,
Cardoso Fatima,
Andersen Jay,
Patt Debra,
Danso Michael,
Ferreira Marta,
Mouret-Reynier Marie-Ange,
Im Seock-Ah,
Ahn Jin-Hee,
Gion Maria,
Baron-Hay Sally,
Boileau Jean-François,
Ding Yu,
Tryfonidis Konstantinos,
Aktan Gursel,
Karantza Vassiliki,
O’Shaughnessy Joyce
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 386, № 6, с. 556-567
DOI
-
-
2022
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
-
Schmid Peter,
Cortes Javier,
Dent Rebecca,
Pusztai Lajos,
McArthur Heather,
Kümmel Sherko,
Bergh Jonas,
Denkert Carsten,
Park Yeon Hee,
Hui Rina,
Harbeck Nadia,
Takahashi Masato,
Untch Michael,
Fasching Peter A.,
Cardoso Fatima,
Andersen Jay,
Patt Debra,
Danso Michael,
Ferreira Marta,
Mouret-Reynier Marie-Ange,
Im Seock-Ah,
Ahn Jin-Hee,
Gion Maria,
Baron-Hay Sally,
Boileau Jean-François,
Ding Yu,
Tryfonidis Konstantinos,
Aktan Gursel,
Karantza Vassiliki,
O’Shaughnessy Joyce,
Ganshina Inna
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 386, № 6, с. 556-567
DOI
-
-
2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
-
Modi Shanu,
Jacot William,
Yamashita Toshinari,
Sohn Joohyuk,
Vidal Maria,
Tokunaga Eriko,
Tsurutani Junji,
Ueno Naoto T.,
Prat Aleix,
Chae Yee Soo,
Lee Keun Seok,
Niikura Naoki,
Park Yeon Hee,
Xu Binghe,
Wang Xiaojia,
Gil-Gil Miguel,
Li Wei,
Pierga Jean-Yves,
Im Seock-Ah,
Moore Halle C.F.,
Rugo Hope S.,
Yerushalmi Rinat,
Zagouri Flora,
Gombos Andrea,
Kim Sung-Bae,
Liu Qiang,
Luo Ting,
Saura Cristina,
Schmid Peter,
Sun Tao,
Gambhire Dhiraj,
Yung Lotus,
Wang Yibin,
Singh Jasmeet,
Vitazka Patrik,
Meinhardt Gerold,
Harbeck Nadia,
Cameron David A.
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 387, № 1, с. 9-20
DOI
-
-
2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
-
Modi Shanu,
Jacot William,
Yamashita Toshinari,
Sohn Joohyuk,
Vidal Maria,
Tokunaga Eriko,
Tsurutani Junji,
Ueno Naoto T.,
Prat Aleix,
Chae Yee Soo,
Lee Keun Seok,
Niikura Naoki,
Park Yeon Hee,
Xu Binghe,
Wang Xiaojia,
Gil-Gil Miguel,
Li Wei,
Pierga Jean-Yves,
Im Seock-Ah,
Moore Halle C.F.,
Rugo Hope S.,
Yerushalmi Rinat,
Zagouri Flora,
Gombos Andrea,
Kim Sung-Bae,
Liu Qiang,
Luo Ting,
Saura Cristina,
Schmid Peter,
Sun Tao,
Gambhire Dhiraj,
Yung Lotus,
Wang Yibin,
Singh Jasmeet,
Vitazka Patrik,
Meinhardt Gerold,
Harbeck Nadia,
Cameron David A.,
Ganshina Inna
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 387, № 1, с. 9-20
DOI
-
-
2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
-
Modi Shanu,
Jacot William,
Yamashita Toshinari,
Sohn Joohyuk,
Vidal Maria,
Tokunaga Eriko,
Tsurutani Junji,
Ueno Naoto T.,
Prat Aleix,
Chae Yee Soo,
Lee Keun Seok,
Niikura Naoki,
Park Yeon Hee,
Xu Binghe,
Wang Xiaojia,
Gil-Gil Miguel,
Li Wei,
Pierga Jean-Yves,
Im Seock-Ah,
Moore Halle C.F.,
Rugo Hope S.,
Yerushalmi Rinat,
Zagouri Flora,
Gombos Andrea,
Kim Sung-Bae,
Liu Qiang,
Luo Ting,
Saura Cristina,
Schmid Peter,
Sun Tao,
Gambhire Dhiraj,
Yung Lotus,
Wang Yibin,
Singh Jasmeet,
Vitazka Patrik,
Meinhardt Gerold,
Harbeck Nadia,
Cameron David A.
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 387, № 1, с. 9-20
DOI
-
-
2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
-
Modi Shanu,
Jacot William,
Yamashita Toshinari,
Sohn Joohyuk,
Vidal Maria,
Tokunaga Eriko,
Tsurutani Junji,
Ueno Naoto T.,
Prat Aleix,
Chae Yee Soo,
Lee Keun Seok,
Niikura Naoki,
Park Yeon Hee,
Xu Binghe,
Wang Xiaojia,
Gil-Gil Miguel,
Li Wei,
Pierga Jean-Yves,
Im Seock-Ah,
Moore Halle C.F.,
Rugo Hope S.,
Yerushalmi Rinat,
Zagouri Flora,
Gombos Andrea,
Kim Sung-Bae,
Liu Qiang,
Luo Ting,
Saura Cristina,
Schmid Peter,
Sun Tao,
Gambhire Dhiraj,
Yung Lotus,
Wang Yibin,
Singh Jasmeet,
Vitazka Patrik,
Meinhardt Gerold,
Harbeck Nadia,
Cameron David A.
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 387, № 1, с. 9-20
DOI
-
-
2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
-
Modi Shanu,
Jacot William,
Yamashita Toshinari,
Sohn Joohyuk,
Vidal Maria,
Tokunaga Eriko,
Tsurutani Junji,
Ueno Naoto T.,
Prat Aleix,
Chae Yee Soo,
Lee Keun Seok,
Niikura Naoki,
Park Yeon Hee,
Xu Binghe,
Wang Xiaojia,
Gil-Gil Miguel,
Li Wei,
Pierga Jean-Yves,
Im Seock-Ah,
Moore Halle C.F.,
Rugo Hope S.,
Yerushalmi Rinat,
Zagouri Flora,
Gombos Andrea,
Kim Sung-Bae,
Liu Qiang,
Luo Ting,
Saura Cristina,
Schmid Peter,
Sun Tao,
Gambhire Dhiraj,
Yung Lotus,
Wang Yibin,
Singh Jasmeet,
Vitazka Patrik,
Meinhardt Gerold,
Harbeck Nadia,
Cameron David A.
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 387, № 1, с. 9-20
DOI
-
-
2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
-
Harbeck N.,
Rastogi P.,
Martin M.,
Tolaney S.M.,
Shao Z.M.,
Fasching P.A.,
Huang C.S.,
Jaliffe G.G.,
Tryakin A.,
Goetz M.P.,
Rugo H.S.,
Senkus E.,
Testa L.,
Andersson M.,
Tamura K.,
Mastro L.Del,
Steger G.G.,
Kreipe H.,
Hegg R.,
Sohn J.,
Guarneri V.,
Cortés J.,
Hamilton E.,
André V.,
Wei R.,
Barriga S.,
Sherwood S.,
Forrester T.,
Munoz M.,
Shahir A.,
Antonio B.San,
Nabinger S.C.,
Toi M.,
Johnston S.R.D,
O’Shaughnessy J.,
Jimenez M.M.,
Johnston S.,
Boyle F.,
Steger G.G.,
Neven P.,
Jiang Z.,
Campone M.,
Huober J.,
Shimizu C.,
Cicin I.,
Wardley A.,
Tolaney S.M.,
Abuin G.G.,
Zarba J.,
Lim E.,
Sant P.,
Liao N.,
Christiansen B.,
Eigeliene N.,
Martin-Babau J.,
Ettl J.,
Mavroudis D.,
Chiu J.,
Boer K.,
Nagarkar R.,
Paluch-Shimon S.,
Moscetti L.,
Sagara Y.,
Kim S.B.,
Maciel M.M.,
Tjan-Heijnen V.,
Broom R.,
Lacko A.,
Schenker M.,
Volkov N.,
Yap Y.Sim,
Coccia-Portugal M.,
Sáenz J.Ángel García,
Andersson A.,
Chao T.Y.,
Gokmen E.,
Harputluoglu H.,
Berzoy O.,
Patt D.,
McArthur H.,
Chew H.,
Chalasani P.,
Kaufman P.,
Tedesco K.,
Graff S.L.
-
в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 32, № 12, с. 1571-1581
DOI
-
-
2021
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
-
Harbeck N.,
Rastogi P.,
Martin M.,
Tolaney S.M.,
Shao Z.M.,
Fasching P.A.,
Huang C.S.,
Jaliffe G.G.,
Tryakin A.,
Goetz M.P.,
Rugo H.S.,
Senkus E.,
Testa L.,
Andersson M.,
Tamura K.,
Mastro L.Del,
Steger G.G.,
Kreipe H.,
Hegg R.,
Sohn J.,
Guarneri V.,
Cortés J.,
Hamilton E.,
André V.,
Wei R.,
Barriga S.,
Sherwood S.,
Forrester T.,
Munoz M.,
Shahir A.,
Antonio B.San,
Nabinger S.C.,
Toi M.,
Johnston S.R.D,
O’Shaughnessy J.,
Jimenez M.M.,
Johnston S.,
Boyle F.,
Steger G.G.,
Neven P.,
Jiang Z.,
Campone M.,
Huober J.,
Shimizu C.,
Cicin I.,
Wardley A.,
Tolaney S.M.,
Abuin G.G.,
Zarba J.,
Lim E.,
Sant P.,
Liao N.,
Christiansen B.,
Eigeliene N.,
Martin-Babau J.,
Ettl J.,
Mavroudis D.,
Chiu J.,
Boer K.,
Nagarkar R.,
Paluch-Shimon S.,
Moscetti L.,
Sagara Y.,
Kim S.B.,
Maciel M.M.,
Tjan-Heijnen V.,
Broom R.,
Lacko A.,
Schenker M.,
Volkov N.,
Yap Y.Sim,
Coccia-Portugal M.,
Sáenz J.Ángel García,
Andersson A.,
Chao T.Y.,
Gokmen E.,
Harputluoglu H.,
Berzoy O.,
Patt D.,
McArthur H.,
Chew H.,
Chalasani P.,
Kaufman P.,
Tedesco K.,
Graff S.L.
-
в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 32, № 12, с. 1571-1581
DOI
-
-
2021
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
-
Burstein H.J.,
Curigliano G.,
Thürlimann B.,
Weber W.P.,
Poortmans P.,
Regan M.M.,
Senn H.J.,
Winer E.P.,
Gnant M.,
Aebi Stephan,
André Fabrice,
Barrios Carlos,
Bergh Jonas,
Bonnefoi Herve,
Morales Denisse Bretel,
Brucker Sara,
Burstein Harold,
Cameron David,
Cardoso Fatima,
Carey Lisa,
Chua Boon,
Ciruelos Eva,
Colleoni Marco,
Curigliano Giuseppe,
Delaloge Suzette,
Denkert Carsten,
Dubsky Peter,
Ejlertsen Bent,
Fitzal Florian,
Francis Prudence,
Galimberti Viviana,
Mahmoud Hebatallah Gamal El Din Mohamed,
Garber Judy,
Gnant Michael,
Gradishar William,
Gulluoglu Bahadir,
Harbeck Nadia,
Huang Chiun-Sheng,
Huober Jens,
Ilbawi Andre,
Jiang Zefei,
Johnston Steven,
Lee Eun Sook,
Loibl Sibylle,
Morrow Monica,
Partridge Ann,
Piccart Martine,
Prat Aleix,
Regan Meredith,
Rubio Isabella,
Rugo Hope,
Rutgers Emiel,
Sedlmayer Felix,
Semiglazov Vladimir,
Senn Hans-Joerg,
Shao Zhiming,
Spanic Tanja,
Tesarova Petra,
Thürlimann Beat,
Tjulandin Sergei,
Toi Masakazu,
Trudeau Maureen,
Turner Nicholas,
Luis Inez Vaz,
Viale Giuseppe,
Watanabe Toru,
Weber Walter P.,
Winer Eric P.,
Xu Binghe
-
в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 32, № 10, с. 1216-1235
DOI
-
-
2021
Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer
-
Joyce A.O'Shaughnessy,
Johnston Stephen,
Harbeck Nadia,
Toi Masakazu,
Im Young-Hyuck,
Reinisch Mattea,
Shao Zhimin,
Kellokumpu Lehtinen Pirkko Liisa,
Huang Chiun-Sheng,
Tryakin Alexey
-
в журнале Clinical Advances in Hematology and Oncology, издательство Millenium Medical Publishing, Inc. (United States), том 19, № 2, с. 15-16
-
-
2021
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
-
Miles D.,
Gligorov J.,
André F.,
Cameron D.,
Schneeweiss A.,
Barrios C.,
Xu B.,
Wardley A.,
Kaen D.,
Andrade L.,
Semiglazov V.,
Reinisch M.,
Patel S.,
Patre M.,
Morales L.,
Patel S.L.,
Kaul M.,
Barata T.,
O’Shaughnessy J.,
Zhang Q.,
Xu B.,
Shao Z.,
Wang X.,
Geng C.,
Yan X.,
Tong Z.,
Shen K.,
Yin Y.,
Sun T.,
Yang J.,
Feng J.,
Yan M.,
Wang Y.,
Liu Q.,
Zhang S.,
Laurentiis M.De,
Santoro A.,
Guarneri V.,
Colleoni M.,
Natoli C.,
Cortesi L.,
Placido S.,
Gianni L.,
Ferrau F.,
Livi L.,
Zambelli A.,
Mastro L.Del,
Tonini G.,
Montemurro F.,
Bianchi G.,
Pedersini R.,
Prete S.,
Allegrini G.,
Naso G.,
Vici P.,
Loirat D.,
Mailliez A.,
Priou F.,
Tredan O.,
Dalenc F.,
Perrin C.,
David M.Timar,
Dohollou N.,
Teixeira L.,
Brocard F.,
Arnaud A.,
Delaloge S.,
Spano J.P.,
Mansi L.,
Damian F.,
Pedrini J.,
Aleixo S.,
Hegg R.,
Junior R.,
Reinisch M.,
Schmidt M.,
Wenzel C.,
Grischke E.M.,
Schneeweiss A.,
Just M.,
Harbeck N.,
Schumacher C.,
Peters U.,
Fischer D.,
Forstbauer H.,
Liersch R.,
Warner E.,
Bouganim N.,
Doyle C.,
Hiller J.Price,
Vandenberg T.,
Pavic M.,
Robinson A.,
Urgoiti G.Roldan,
Califaretti N.,
Alacacioglu A.,
Gumus M.,
Yalcin B.,
Cicin I.,
Kose F.,
Uygun K.,
Kaplan M.,
Cubukcu E.,
Harries M.,
Miles D.,
Doval D.,
Gupta S.,
Mohapatra P.,
Chatterjee S.,
Ghadyalpatil N.,
Singhal M.,
Nag S.,
Agarwal A.,
Wolf I.,
Yam E.Gal,
Yerushalmi R.,
Peretz T.,
Fried G.,
Baruch N.Ben,
Katz D.,
Hamilton E.,
Kayali F.,
Brufsky A.,
Telli M.,
Wright G.,
Oyola R.,
Rakowski T.,
Graff S.,
Tjulandin S.,
Semiglazov V.,
Aparicio A.,
Borrego M.Ruiz,
Merino L.,
Martinez J.Guerra,
Lopez E.,
Yamashita T.,
Ohtani S.,
Inoue K.,
Ito Y.,
Niikura N.,
Nakayama T.,
Sagara Y.,
Yanagita Y.,
Kamada Y.,
Kaneko K.,
Kaen D.,
Nervo A.,
Eniu A.,
Schenker M.,
Priester P.,
Melichar B.,
Zimovjanova M.,
Sormova P.,
Sufliarsky J.,
Kakalejcik M.,
Belbaraka R.,
Errihani H.,
Than D.Le,
Pham D.,
Aravantinos G.,
Papadimitriou C.,
Koumakis G.,
Papandreou C.,
Podolski P.,
Tabane K.
-
в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 32, № 8, с. 994-1004
DOI
-
-
2020
Pembrolizumab for Early Triple-Negative Breast Cancer
-
Schmid Peter,
Cortes Javier,
Pusztai Lajos,
McArthur Heather,
Kümmel Sherko,
Bergh Jonas,
Denkert Carsten,
Park Yeon Hee,
Hui Rina,
Harbeck Nadia,
Takahashi Masato,
Foukakis Theodoros,
Fasching Peter A.,
Cardoso Fatima,
Untch Michael,
Jia Liyi,
Karantza Vassiliki,
Zhao Jing,
Aktan Gursel,
Dent Rebecca,
O’Shaughnessy Joyce
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 382, № 9, с. 810-821
DOI
-
-
2020
Pembrolizumab for Early Triple-Negative Breast Cancer
-
Schmid Peter,
Cortes Javier,
Pusztai Lajos,
McArthur Heather,
Kümmel Sherko,
Bergh Jonas,
Denkert Carsten,
Park Yeon Hee,
Hui Rina,
Harbeck Nadia,
Takahashi Masato,
Foukakis Theodoros,
Fasching Peter A.,
Cardoso Fatima,
Untch Michael,
Jia Liyi,
Karantza Vassiliki,
Zhao Jing,
Aktan Gursel,
Dent Rebecca,
O’Shaughnessy Joyce,
Ganshina Inna
-
в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 382, № 9, с. 810-821
DOI
-
-
2019
Auto-regulation of Rab5 GEF activity in Rabex5 by allosteric structural changes, catalytic core dynamics and ubiquitin binding
-
Lauer Janelle,
Segeletz Sandra,
Cezanne Alice,
Guaitoli Giambattista,
Raimondi Francesco,
Gentzel Marc,
Alva Vikram,
Habeck Michael,
Kalaidzidis Yannis,
Ueffing Marius,
Lupas Andrei N.,
Gloeckner Christian Johannes,
Zerial Marino
-
в журнале eLife, том 8, с. e46302
DOI
-
-
2016
RANDOMIZED, DOUBLE -BLIND STUDY COMPARING PROPOSED BIOSIMILAR LA-EP2006 WITH REFERENCE PEGFILGRASTIM IN BREAST CANCER
-
Harbeck N.,
Lipatov O.,
Frolova M.,
Udovitsa D.,
Topuzov E.,
Ganea-Motan D.E.,
Nakov R.,
Singh P.,
Rudy A.,
Blackwell K.
-
в журнале Future Oncology, издательство Future Medicine Ltd. (United Kingdom), том 12, № 1, с. 1-29
-
-
2016
RANDOMIZED, DOUBLE-BLIND STUDY COMPARING PROPOSED BIOSIMILAR LA-EP2006 WITH REFERENCE PEGFILGRASTIM IN BREAST CANCER
-
Harbeck N.,
Lipatov O.,
Frolova M.,
Udovitsa D.,
Topuzov E.,
Ganea-Motan D.E.,
Nakov R.,
Singh P.,
Rudy A.,
Blackwell K.
-
в журнале Future Oncology, издательство Future Medicine Ltd. (United Kingdom), том 12, № 11, с. 1359-1367